Publications by authors named "Zanotti R"

Purpose: The primary challenge in infant care is developing a comprehensive, rapid, and reliable assessment tool that is minimally dependent on subjective evaluations and applicable in various inpatient settings. This study aims to develop and assess the structural validity of the Infant Nursing Assessment Scale (INA), enabling a comprehensive evaluation of hospitalized newborns and infants.

Design And Methods: A development and validation study based on cross-sectional design was undertaken.

View Article and Find Full Text PDF

According to the Food and Agriculture Organization of the United Nations (FAO) more than 14% of the world's food production is lost every year before reaching retail, and another 17% is lost during the retail stage. The use of the expiration date as the main estimator of the life-end of food products creates unjustified food waste. Sensors capable of quantifying the effective food freshness and quality could substantially reduce food waste and enable more effective management of the food chain.

View Article and Find Full Text PDF

Background: Heart transplantation (HT) recipients often report improved quality of life and increased overall happiness, viewing the transplantation as a rebirth and a second chance at life. However, interpretations of normality vary among individuals. Understanding patients' and caregivers' experiences in depth is crucial to adjust clinical care paths and avoid complications.

View Article and Find Full Text PDF

Background: Comprehending and addressing the needs of caregivers during the post-intensive care unit (ICU) phase is vital for establishing sustainable support systems and improving the overall quality of life (QoL) for both patients and caregivers.

Objective: To explore the experiences of family members (FMs) caring for loved ones three-months after ICU discharge and their related QoL.

Methods And Measures: A qualitative, descriptive research was conducted.

View Article and Find Full Text PDF

A framework for electrolyte-gated organic transistors (EGOTs) that unifies the view of interfacial capacitive coupling of electrolyte-gated organic field-effect transistors (EGOFETs) with the volumetric capacitive coupling in organic electrochemical transistors (OECTs) is proposed. The EGOT effective capacitance arises from in-series capacitances of the electrolyte/gate electrode and electrolyte/channel interfaces, and the chemical capacitance of the organic semiconductor channel whose weight with respect to the interfacial capacitance is modulated by the charge carrier density, hence by the gate voltage. The expression for chemical capacitance is derived from the DOS of the organic semiconductor, which it is assumed to exhibit exponential energy disorder in the HOMO-LUMO gap.

View Article and Find Full Text PDF
Article Synopsis
  • - Mastocytosis is a disorder characterized by an abnormal increase of mast cells in one or more organs, with varying symptoms and outcomes; it's classified into cutaneous, systemic, and MC sarcoma types by the WHO.
  • - The disease often involves a specific mutation (D816V) in most systemic mastocytosis cases, affecting life expectancy significantly based on the type, with those having nonadvanced forms generally living near-normal lifespans, while advanced forms have limited life expectancies.
  • - Recently, a group of experts proposed updated diagnostic criteria and classifications for mastocytosis, aiming to unify different classifications from previous organizations to improve research and clinical comparisons.
View Article and Find Full Text PDF
Article Synopsis
  • * Screening includes examining the skin, measuring baseline serum tryptase, and using specific scoring systems, with a bone marrow biopsy recommended for higher-risk patients.
  • * Treatment for those with both conditions involves long-term immunotherapy for the venom and carrying multiple epinephrine autoinjectors, while future research aims to explore targeted therapies for related anaphylactic reactions.
View Article and Find Full Text PDF

Immune-mediated inflammatory diseases (IMIDs) are chronic diseases that are associated with an inflammatory process with unclear etiology and occur in genetically predisposed individuals. In this study, inflammatory bowel disease (IBD) and rheumatic disease (RD) were examined. The aim of the research is to evaluate the relationship between IMID and state anxiety and work impairment in patients.

View Article and Find Full Text PDF

Background: A score to predict the association between unexplained osteoporosis and an underlying systemic Mastocytosis (SM) is lacking.

Objective: This study aimed at identifying criteria able to predict the diagnosis of SM without skin involvement and provide an indication for bone marrow (BM) assessment.

Methods: We included 139 adult patients with unexplained osteoporosis and suspected SM.

View Article and Find Full Text PDF

Introduction: The objective of this study was to stratify preoperative immune cell counts by cancer specific outcomes in patients with renal cell carcinoma (RCC) and a tumor thrombus after radical nephrectomy with tumor thrombectomy.

Methods: Patients with a diagnosis of RCC with tumor thrombus that underwent radical nephrectomy with thrombectomy across an international consortium of seven institutions were included. Patients who were metastatic at diagnosis and those who received preoperative medical treatment were also included.

View Article and Find Full Text PDF
Article Synopsis
  • Hypersensitivity reactions (HR) are common in mastocytosis, a condition analyzed using data from the European Competence Network on Mastocytosis (ECNM), involving 2485 adults.
  • About 38.1% of patients reported HR, with Hymenoptera venoms being the primary trigger for cutaneous mastocytosis and indolent systemic mastocytosis, while drug reactions were more common in advanced systemic mastocytosis.
  • Key risk factors for HR include lower tryptase levels, minimal mast cell infiltration in bone marrow, and a diagnosis of indolent systemic mastocytosis, with new reactions occurring in 4.8% of patients over four years.
View Article and Find Full Text PDF

Certain laboratory abnormalities correlate with subvariants of systemic mastocytosis (SM) and are often prognostically relevant. To assess the diagnostic and prognostic value of individual serum chemistry parameters in SM, 2607 patients enrolled within the European Competence Network on Mastocytosis and 575 patients enrolled within the German Registry on Eosinophils and Mast Cells were analyzed. For screening and diagnosis of SM, tryptase was identified as the most specific serum parameter.

View Article and Find Full Text PDF

Purpose: Patients with post prostatectomy incontinence (PPI) seem to have different needs. Therefore, device post-operative readjustability may be a beneficial feature in PPI management, even though it lacks study support. The purpose of this study is to describe our surgical technique for male sling (MS) implantation, assess outcomes, and the impact of readjustability.

View Article and Find Full Text PDF
Article Synopsis
  • - In advanced systemic mastocytosis (AdvSM), cytoreductive treatment is becoming more diverse, particularly with new medications like KIT tyrosine kinase inhibitors.
  • - Avapritinib, a second-generation drug specifically targeting the D816V mutation, has gained approval from US FDA and EMA for treating adults with AdvSM based on successful clinical trial results.
  • - An Italian compassionate use program showed that avapritinib is effective for patients who have undergone multiple treatments, providing significant responses and potentially helping as a temporary treatment before an allogeneic transplant, though careful monitoring for side effects is necessary.
View Article and Find Full Text PDF

Among hospitalised patients, functional decline and increased dependence on others are common health problems. Identifying critical needs is an important starting point to empower patients to improve their own health and behaviour. Once these needs are determined, the most relevant goals for addressing patients' needs and health potential can be established.

View Article and Find Full Text PDF

In Italy, from April 2021, healthcare workers were required to receive the COVID-19 vaccine; if they refused it, an immediate unpaid suspension was implemented until they received the vaccine. Although there are numerous quantitative studies on the factors that influenced vaccine hesitancy during the COVID-19 pandemic, qualitative research on the causes of vaccine refusal is still missing. This research aimed to investigate the phenomenon of nurses who refused to receive COVID-19 vaccination despite being required to do so, as well as the reasons behind their refusal.

View Article and Find Full Text PDF

Quality measurement of the intensive care unit (ICU) should include families' perspectives, their satisfaction with the care process and outcomes, and the evaluation of actions to improve their psychological health and wellbeing. The current study was designed to validate the Italian version of the Family Satisfaction in the Intensive Care Unit (FS-ICU) using the Rasch model. Results included reliability and separation for items and persons, item fit statistics, unidimensionality, and item characteristic curve.

View Article and Find Full Text PDF

Aggressive SM + AML has limited therapeutic options. Even a strong combination of decitabine-venetoclax-midostaurin has a transient effect on AML and a mitigated effect on SM. Larger series are required to identify the best therapeutic strategy.

View Article and Find Full Text PDF

Background: The SETD2 tumor suppressor gene encodes a histone methyltransferase that safeguards transcription fidelity and genomic integrity via trimethylation of histone H3 lysine 36 (H3K36Me3). SETD2 loss of function has been observed in solid and hematologic malignancies. We have recently reported that most patients with advanced systemic mastocytosis (AdvSM) and some with indolent or smoldering SM display H3K36Me3 deficiency as a result of a reversible loss of SETD2 due to reduced protein stability.

View Article and Find Full Text PDF

In 2002, the European Competence Network on Mastocytosis (ECNM) was launched as a multidisciplinary collaborative initiative to increase the awareness and to improve diagnosis and management of patients with mast cell (MC) disorders. The ECNM consists of a net of specialized centers, expert physicians, and scientists who dedicate their work to MC diseases. One essential aim of the ECNM is to timely distribute all available information about the disease to patients, doctors, and scientists.

View Article and Find Full Text PDF
Article Synopsis
  • Incorporating real-world data into drug development enhances health outcomes by reflecting actual drug safety and efficacy patterns.
  • A study with 154 myelofibrosis patients treated with ruxolitinib showed a median drug exposure of 29 months, with a 27% discontinuation rate primarily due to infections and hematological toxicities matching previous research.
  • Significant spleen response was observed in 68% of patients, correlating with improved overall survival, while factors like larger splenomegaly and delayed treatment onset negatively impacted outcomes.
View Article and Find Full Text PDF
Article Synopsis
  • - The study investigates the prevalence and severity of hypersensitivity reactions to NSAIDs in patients with mastocytosis, who may be more susceptible to these reactions due to their condition, especially after experiencing anaphylaxis from insect stings.
  • - Conducted with 388 patients from two European centers, the findings revealed an NSAID-hypersensitivity prevalence of 11.3%, primarily presenting as skin reactions, with only a small number (2.8%) experiencing severe anaphylaxis.
  • - Overall, the results suggest that mastocytosis patients can typically use NSAIDs safely if they have no prior adverse reactions, while those with a history of NSAID reactions should seek a comprehensive allergy evaluation before use.
View Article and Find Full Text PDF

Background: Organomegaly, including splenomegaly, hepatomegaly, and/or lymphadenopathy, are important diagnostic and prognostic features in patients with cutaneous mastocytosis (CM) or systemic mastocytosis (SM).

Objectives: To investigate the prevalence and prognostic impact of 1 or more organomegalies on clinical course and survival in patients with CM/SM.

Methods: Therefore, 3155 patients with CM (n = 1002 [32%]) or SM (n = 2153 [68%]) enrolled within the registry of the European Competence Network on Mastocytosis were analyzed.

View Article and Find Full Text PDF